{"id":7387,"date":"2024-08-15T13:14:10","date_gmt":"2024-08-15T13:14:10","guid":{"rendered":"https:\/\/www.bedfont.com\/?p=1190"},"modified":"2024-11-18T07:07:56","modified_gmt":"2024-11-18T07:07:56","slug":"addressing-primary-care-challenges-with-the-nobreath","status":"publish","type":"post","link":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/","title":{"rendered":"Addressing Primary Care Challenges with the NObreath\u00ae"},"content":{"rendered":"\n

FeNO Testing in Asthma Care<\/strong><\/p>\n\n\n\n

Although airway eosinophilic inflammation is a key characteristic of asthma, there are few methods available to measure it. This inflammation can be assessed by measuring eosinophils and eosinophilic cationic protein (ECP) in sputum or by measuring ECP in blood samples1<\/sup>. However, these methods are considered time-consuming, expensive, and not readily available.<\/p>\n\n\n\n

For most asthma patients, airway inflammation is driven by an allergen-induced Th2 response2<\/sup>. Evidence from the literature suggests that fractional exhaled nitric oxide (FeNO) is a crucial biomarker for respiratory tract inflammation2<\/sup>. Elevated FeNO levels in asthma are thought to result from inducible NOS2 expression in the inflamed airways2<\/sup>. The NObreath\u00ae FeNO device provides a non-invasive and significantly more cost-effective alternative aid to diagnose asthma and assess airway eosinophilic inflammation.<\/p>\n\n\n\n

This article delves into the challenges encountered within primary care and how the innovative technology of the NObreath\u00ae can assist. Additionally, the article discusses the transition of the use of the NObreath\u00ae from primary care environments to secondary care facilities.<\/p>\n\n\n\n

<\/p>\n\n\n\n

Challenges in Primary Care<\/strong><\/p>\n\n\n\n

GPs often face restricted budgets due to resource allocation for population needs, and financial sustainability to stay within healthcare budgets and prevent overspending. Each patient appointment is typically limited to just 10 minutes.<\/p>\n\n\n\n

<\/p>\n\n\n\n

Population needs<\/em><\/p>\n\n\n\n

In the UK, approximately 5.4 million people, or about 8 in every 100 individuals, suffer from asthma3<\/sup>. The National Review of Asthma Deaths (NRAD) documented 195 asthma-related deaths among adults in 2013, highlighting preventable factors in 89 of the 195 deaths (46%), such as lack of specific asthma expertise (17%) and non-adherence to UK asthma guidelines (25%)4<\/sup>. FeNO testing is valuable in GP settings, as GPs often encounter a spectrum of asthma cases, from mild to severe. The NObreath\u00ae device facilitates rapid and reliable FeNO measurements, to allow GPs to make informed decisions and aid in identifying patients who do or do not require ongoing treatment5<\/sup>. This also reduces emergency visits and hospital admissions related to poorly controlled asthma.<\/p>\n\n\n\n

<\/p>\n\n\n\n

Financial sustainability<\/em><\/p>\n\n\n\n

One of the ongoing challenges in primary care is maintaining financial sustainability. The NObreath\u00ae FeNO device is cost-effective, with minimal ongoing costs. The device requires only one consumable- the NObreath\u00ae mouthpiece which has a long shelf life and an integrated infection control filter, effectively removes airborne bacteria (>99%) and viruses (>98%)6<\/sup>. The device also incurs low annual servicing costs and imposes no test limits*.<\/p>\n\n\n\n

<\/p>\n\n\n\n

Time with patient<\/em><\/p>\n\n\n\n

When a GP determines the need for a FeNO test using the NObreath\u00ae, there’s no warm-up time, and the device operates through a simple exhale-only technique with on-screen visual guidance. Patients receive instant results, eliminating wait times. Intended for adult and paediatric patients**, the NObreath\u00ae offers two test modes: a 10-second test mode for those up to 10 years old who cannot complete the 12-second test mode.  GPs can store up to 25 results in up to 50 patient profiles and view a graph of results. If a GP office possesses only one NObreath\u00ae, they benefit from the device size and portability, ensuring that healthcare providers can efficiently utilise the device wherever patient care demands.<\/p>\n\n\n\n

Carol Stonham, a member of Bedfont\u00ae Scientific Limited Medical Advisory Board and policy lead for Policy Care Respiratory Society (PCRS), comments \u201cThe NObreath\u00ae is my preferred choice for primary care in managing asthma for many reasons. Primarily it suits the unpredictability of the volume of testing in primary care – none of the consumables or device needs to be used or lost in a short time frame. It is an intuitive machine which is easy to use and teaches patients of all ages.\u201d<\/p>\n\n\n\n

<\/p>\n\n\n\n

Primary Care to Secondary Care<\/strong><\/p>\n\n\n\n

Using the NObreath\u00ae device in primary care can reduce the number of inappropriate referrals to secondary care clinics. However, if a patient is referred to an asthma specialist in secondary care, the NObreath\u00ae FeNO device can aid in the diagnosis and management of asthma. The NObreath\u00ae helps differentiate between allergic (eosinophilic) and non-allergic asthma7<\/sup>. FeNO measurements show the patient\u2019s response to the treatment, enabling accurate prescription of medication and safer, monitored adjustments. This helps patients understand their condition better by demonstrating how their FeNO levels correlate with their symptoms and treatment adherence. Measuring airway inflammation with the NObreath\u00ae can help monitor the effectiveness of medication and predict the risk of asthma attacks8<\/sup>***<\/p>\n\n\n\n

<\/p>\n\n\n\n

Gold Standard FeNO Testing<\/strong><\/p>\n\n\n\n

FeNO testing is increasingly recognised as a valuable tool in the management of asthma, but what makes the NObreath\u00ae stand out from other FeNO devices on the market? Developed by Bedfont\u00ae in 2008, the NObreath\u00ae has over 15 years of clinical use and has been featured in numerous studies worldwide, contributing to the advancement of FeNO testing. Conforming to both the American Thoracic Society (ATS) and European Respiratory Society (ERS) guidelines, the NObreath\u00ae is also one of three FeNO devices recommended by the National Institute for Health Care Excellence (NICE)9<\/sup>, an independent international organisation providing national guidance and advice to improve health and social care.<\/p>\n\n\n\n

To find out how you can support your patients with FeNO testing in asthma care with the NObreath\u00ae, please visit: https:\/\/www.nobreathfeno.com\/<\/a><\/p>\n\n\n\n

*The NObreath\u00ae has been validated for up to 29,000 tests when used as instructed and properly maintained and serviced. The number of tests can be periodically checked within the settings of the device; when 29,000 tests are reached a service is recommended. Contact your local service centre.<\/p>\n\n\n\n

**NObreath\u00ae can be used on paediatric and adult patients, provided they can follow test protocol. USA only: NObreath\u00ae can be used on patients 7+ years old.<\/p>\n\n\n\n

***FeNO is not a definitive indication of asthma and should be used in conjunction with (but not limited to) spirometry, patient history, and symptoms.<\/p>\n\n\n\n

<\/p>\n\n\n\n

References:<\/strong><\/p>\n\n\n\n

    \n
  1. Pizzichini E, Pizzichini MM, Efthimiadis A, Dolovich J, Hargreave FE. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. Journal of allergy and clinical immunology. 1997 Apr 1;99(4):539-44. DOI: 10.1016\/S0091-6749(97)70082-4.<\/li>\n\n\n\n
  2. Keller AC, Rodriguez D, Russo M. Nitric oxide paradox in asthma. Mem\u00f3rias do Instituto Oswaldo Cruz. 2005;100:19-23. PMID: 15962094 DOI: 10.1590\/s0074-02762005000900005.<\/li>\n\n\n\n
  3. What is Asthma? [Internet]. Asthma+ Lung UK. 2024. [Cited Monday 8th<\/sup> July 2024]. Available from: https:\/\/www.asthmaandlung.org.uk\/conditions\/asthma\/what-asthma#:~:text=Asthma%20is%20a%20common%20condition,cough%20or%20a%20tight%20chest<\/a>.<\/li>\n\n\n\n
  4. Royal College of Physicians. Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Report. London, RCP; 2014.<\/li>\n\n\n\n
  5. Taylor DR, Pijnenburg MW, Smith AD, Jongste J. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax. 2006 Sep 1;61(9):817-27. PMID: 16936238 PMCID: PMC2117092 DOI: 10.1136\/thx.2005.056093.<\/li>\n\n\n\n
  6. Public Health England. An Evaluation of Filtration Efficiencies Against Bacterial and Viral Aerosol Challenges. Salisbury: Public Health England; 2020.<\/li>\n\n\n\n
  7. Ref: Coumou H, Bel EH. Improving the diagnosis of eosinophilic asthma. Expert review of respiratory medicine. 2016 Oct 2;10(10):1093-103. DOI: 10.1080\/17476348.2017.1236688.<\/li>\n\n\n\n
  8. Saito J, Gibeon D, Macedo P, Menzies-Gow A, Bhavsar PK, Chung KF. Domiciliary diurnal variation of exhaled nitric oxide fraction for asthma control. European Respiratory Journal. 2014 Feb 1;43(2):474-84. DOI: 10.1183\/09031936.00048513.<\/li>\n\n\n\n
  9. Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath [Internet]. National Institute for Health and Care Excellence. 2014. [Cited Wednesday 10th<\/sup> July 2024]. Available from: https:\/\/www.nice.org.uk\/guidance\/dg12\/chapter\/5-Outcomes<\/a><\/li>\n<\/ol>\n\n\n\n

    <\/p>\n","protected":false},"excerpt":{"rendered":"

    FeNO Testing in Asthma Care Although airway eosinophilic inflammation is a key characteristic of asthma, there are few methods available to measure it. This inflammation can be assessed by measuring eosinophils and eosinophilic cationic protein (ECP) in sputum or by measuring ECP in blood samples1. However, these methods are considered time-consuming, expensive, and not readily […]<\/p>\n","protected":false},"author":6,"featured_media":7388,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7387","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nAddressing Primary Care Challenges with the NObreath\u00ae - Bedfont Scientific Ltd.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Addressing Primary Care Challenges with the NObreath\u00ae - Bedfont Scientific Ltd.\" \/>\n<meta property=\"og:description\" content=\"FeNO Testing in Asthma Care Although airway eosinophilic inflammation is a key characteristic of asthma, there are few methods available to measure it. This inflammation can be assessed by measuring eosinophils and eosinophilic cationic protein (ECP) in sputum or by measuring ECP in blood samples1. However, these methods are considered time-consuming, expensive, and not readily […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/\" \/>\n<meta property=\"og:site_name\" content=\"Bedfont Scientific Ltd.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Bedfontltd\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-15T13:14:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-18T07:07:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2024\/08\/Article-Featured-Images-4.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2240\" \/>\n\t<meta property=\"og:image:height\" content=\"1260\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"websites\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BedfontLtd\" \/>\n<meta name=\"twitter:site\" content=\"@BedfontLtd\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"websites\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/addressing-primary-care-challenges-with-the-nobreath\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/addressing-primary-care-challenges-with-the-nobreath\\\/\"},\"author\":{\"name\":\"websites\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/#\\\/schema\\\/person\\\/8d8a6df6af357a89254fe2e43e21b1f1\"},\"headline\":\"Addressing Primary Care Challenges with the NObreath\u00ae\",\"datePublished\":\"2024-08-15T13:14:10+00:00\",\"dateModified\":\"2024-11-18T07:07:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/addressing-primary-care-challenges-with-the-nobreath\\\/\"},\"wordCount\":1169,\"publisher\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/addressing-primary-care-challenges-with-the-nobreath\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/Article-Featured-Images-4.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/addressing-primary-care-challenges-with-the-nobreath\\\/\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/addressing-primary-care-challenges-with-the-nobreath\\\/\",\"name\":\"Addressing Primary Care Challenges with the NObreath\u00ae - Bedfont Scientific Ltd.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/addressing-primary-care-challenges-with-the-nobreath\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/addressing-primary-care-challenges-with-the-nobreath\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/Article-Featured-Images-4.png\",\"datePublished\":\"2024-08-15T13:14:10+00:00\",\"dateModified\":\"2024-11-18T07:07:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/addressing-primary-care-challenges-with-the-nobreath\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/addressing-primary-care-challenges-with-the-nobreath\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/addressing-primary-care-challenges-with-the-nobreath\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/Article-Featured-Images-4.png\",\"contentUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/Article-Featured-Images-4.png\",\"width\":2240,\"height\":1260},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/addressing-primary-care-challenges-with-the-nobreath\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Addressing Primary Care Challenges with the NObreath\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/\",\"name\":\"Bedfont Scientific Ltd.\",\"description\":\"World leaders in breath analysis.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/#organization\",\"name\":\"Bedfont Scientific Ltd.\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo.png\",\"width\":1600,\"height\":505,\"caption\":\"Bedfont Scientific Ltd.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Bedfontltd\\\/\",\"https:\\\/\\\/x.com\\\/BedfontLtd\",\"https:\\\/\\\/www.instagram.com\\\/bedfontltd\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/bedfont-scientific-ltd\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/BedfontScientificLtd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/#\\\/schema\\\/person\\\/8d8a6df6af357a89254fe2e43e21b1f1\",\"name\":\"websites\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3349652895ce7f1ab3d2a9e8b316a97b06ba43830084011df0c742bd2c90b853?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3349652895ce7f1ab3d2a9e8b316a97b06ba43830084011df0c742bd2c90b853?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3349652895ce7f1ab3d2a9e8b316a97b06ba43830084011df0c742bd2c90b853?s=96&d=mm&r=g\",\"caption\":\"websites\"},\"url\":\"https:\\\/\\\/www.bedfont.com\\\/fr\\\/author\\\/websites\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Addressing Primary Care Challenges with the NObreath\u00ae - Bedfont Scientific Ltd.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/","og_locale":"fr_FR","og_type":"article","og_title":"Addressing Primary Care Challenges with the NObreath\u00ae - Bedfont Scientific Ltd.","og_description":"FeNO Testing in Asthma Care Although airway eosinophilic inflammation is a key characteristic of asthma, there are few methods available to measure it. This inflammation can be assessed by measuring eosinophils and eosinophilic cationic protein (ECP) in sputum or by measuring ECP in blood samples1. However, these methods are considered time-consuming, expensive, and not readily […]","og_url":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/","og_site_name":"Bedfont Scientific Ltd.","article_publisher":"https:\/\/www.facebook.com\/Bedfontltd\/","article_published_time":"2024-08-15T13:14:10+00:00","article_modified_time":"2024-11-18T07:07:56+00:00","og_image":[{"width":2240,"height":1260,"url":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2024\/08\/Article-Featured-Images-4.png","type":"image\/png"}],"author":"websites","twitter_card":"summary_large_image","twitter_creator":"@BedfontLtd","twitter_site":"@BedfontLtd","twitter_misc":{"\u00c9crit par":"websites","Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/#article","isPartOf":{"@id":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/"},"author":{"name":"websites","@id":"https:\/\/www.bedfont.com\/fr\/#\/schema\/person\/8d8a6df6af357a89254fe2e43e21b1f1"},"headline":"Addressing Primary Care Challenges with the NObreath\u00ae","datePublished":"2024-08-15T13:14:10+00:00","dateModified":"2024-11-18T07:07:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/"},"wordCount":1169,"publisher":{"@id":"https:\/\/www.bedfont.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2024\/08\/Article-Featured-Images-4.png","articleSection":["Uncategorized"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/","url":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/","name":"Addressing Primary Care Challenges with the NObreath\u00ae - Bedfont Scientific Ltd.","isPartOf":{"@id":"https:\/\/www.bedfont.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/#primaryimage"},"image":{"@id":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2024\/08\/Article-Featured-Images-4.png","datePublished":"2024-08-15T13:14:10+00:00","dateModified":"2024-11-18T07:07:56+00:00","breadcrumb":{"@id":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/#primaryimage","url":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2024\/08\/Article-Featured-Images-4.png","contentUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2024\/08\/Article-Featured-Images-4.png","width":2240,"height":1260},{"@type":"BreadcrumbList","@id":"https:\/\/www.bedfont.com\/fr\/addressing-primary-care-challenges-with-the-nobreath\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.bedfont.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Addressing Primary Care Challenges with the NObreath\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/www.bedfont.com\/fr\/#website","url":"https:\/\/www.bedfont.com\/fr\/","name":"Bedfont Scientific Ltd.","description":"World leaders in breath analysis.","publisher":{"@id":"https:\/\/www.bedfont.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bedfont.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.bedfont.com\/fr\/#organization","name":"Bedfont Scientific Ltd.","url":"https:\/\/www.bedfont.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.bedfont.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2023\/06\/logo.png","contentUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2023\/06\/logo.png","width":1600,"height":505,"caption":"Bedfont Scientific Ltd."},"image":{"@id":"https:\/\/www.bedfont.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Bedfontltd\/","https:\/\/x.com\/BedfontLtd","https:\/\/www.instagram.com\/bedfontltd\/","https:\/\/www.linkedin.com\/company\/bedfont-scientific-ltd\/","https:\/\/www.youtube.com\/user\/BedfontScientificLtd"]},{"@type":"Person","@id":"https:\/\/www.bedfont.com\/fr\/#\/schema\/person\/8d8a6df6af357a89254fe2e43e21b1f1","name":"websites","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/3349652895ce7f1ab3d2a9e8b316a97b06ba43830084011df0c742bd2c90b853?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3349652895ce7f1ab3d2a9e8b316a97b06ba43830084011df0c742bd2c90b853?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3349652895ce7f1ab3d2a9e8b316a97b06ba43830084011df0c742bd2c90b853?s=96&d=mm&r=g","caption":"websites"},"url":"https:\/\/www.bedfont.com\/fr\/author\/websites\/"}]}},"_links":{"self":[{"href":"https:\/\/www.bedfont.com\/fr\/wp-json\/wp\/v2\/posts\/7387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bedfont.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bedfont.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bedfont.com\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bedfont.com\/fr\/wp-json\/wp\/v2\/comments?post=7387"}],"version-history":[{"count":1,"href":"https:\/\/www.bedfont.com\/fr\/wp-json\/wp\/v2\/posts\/7387\/revisions"}],"predecessor-version":[{"id":7437,"href":"https:\/\/www.bedfont.com\/fr\/wp-json\/wp\/v2\/posts\/7387\/revisions\/7437"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bedfont.com\/fr\/wp-json\/wp\/v2\/media\/7388"}],"wp:attachment":[{"href":"https:\/\/www.bedfont.com\/fr\/wp-json\/wp\/v2\/media?parent=7387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bedfont.com\/fr\/wp-json\/wp\/v2\/categories?post=7387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bedfont.com\/fr\/wp-json\/wp\/v2\/tags?post=7387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}